Skip to main navigation Skip to search Skip to main content

A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient-reported outcomes in patients with relapsing multiple sclerosis transitioning from dimethyl fumarate or fingolimod therapy.

  • Van Der Walt, Anneke (Primary Chief Investigator (PCI))
  • Macdonnell, Richard (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date16/03/21 → 31/12/26

Keywords

  • Multiple sclerosis (MS)
  • Neurological disorders
  • Clinical trial

Clinical Trial Phase

  • Phase III (a & b)